Clinical Trial Results:
"A Phase IIa Randomized, Placebo-Controlled, Parallel Group, Clinical Trial to Study the Efficacy and Safety of MK-2866 in Women with Moderate to Severe Chronic Obstructive Pulmonary Disease Participating in Pulmonary Rehabilitation"
Ensayo clínico de fase IIA, aleatorizado, controlado con placebo y de grupos paralelos para estudiar la eficacia y seguridad de MK-2866 en mujeres con Enfermedad Pulmonar Obstructiva Crónica de moderada a grave que estén participando en una rehabilitación pulmonar
Summary
|
|
EudraCT number |
2009-014657-32 |
Trial protocol |
ES |
Global completion date |
12 Dec 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 May 2019
|
First version publication date |
18 May 2019
|
Other versions |
|
Summary report(s) |
Cancelled/ Withdrawn Memo |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.